Evidence map›Paper›PMID 31632079›Full record

ArticleOncoTargets and therapy2019

Tingting Hu, Xuan Wu, Ke Li, Yuan Li, Ping He, Zhiyuan Wu, Jie Fan, Weiwei Liu, Ming Guan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tingting Hu *Department of Clinical Laboratory, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.ORCID 0000-0001-9580-2089
Xuan Wu *Central Laboratory and Department of Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China.ORCID 0000-0003-1830-8591
Ke LiCentral Laboratory and Department of Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China.
Yuan LiCentral Laboratory and Department of Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China.
Ping HeDepartment of Nuclear Medicine, Nanjing Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
Zhiyuan WuDepartment of Clinical Laboratory, Huashan Hospital North, Fudan University, Shanghai, People's Republic of China.
Jie FanDepartment of Pathology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Weiwei LiuCentral Laboratory and Department of Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China.
Ming GuanDepartment of Clinical Laboratory, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Fudan University · CNTongji University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRestoring lost function to suppressor gene products has captured the interest of the research community in the field of gene therapy.

methodsmiRNAs targeting

resultsAmong all miRNAs, reversed correlation between

conclusionOur findings suggested that oncomiR-183-5p promoted the proliferation, migration, and invasion of CRC cells.

Indexed as

AKAP12 endogenous transcriptscell invasioncell migrationcell proliferationcolorectal cancer cellsmicroRNAoncomiR-183-5p

Identifiers

PMID31632079
PMCPMC6790119
OpenAlexW2977899976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.